"RP-3467, our potential best-in-class Polθ ATPase inhibitor, has demonstrated highly compelling preclinical results, ...

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

--(BUSINESS WIRE)--Revelyst, a collective of world-class maker brands that design and manufacture performance gear and ...

An innovative new database, the Open Source Munitions Portal (OSMP), identifies and shows remnants of explosive devices in ...

The 26-kilowatt LWS combines precision optical and laser hardware ... Leonardo DRS Investor Relations Contacts Steve Vather Senior Vice President, Investor Relations and Corporate Finance +1 703 409 ...

The COVID-19 pandemic gave the global medical community the opportunity to take giant strides forward in understanding how to ...

Bob Woodward’s “War” suggests Biden may have stopped a nuclear war even as Trump was secretly talking to Russia’s president.

Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its ...

MBK Partners won’t raise its bid to gain control of Korea Zinc Co., the private equity group said on Wednesday, days before a ...

bit.ly/CNH_Q3_2024 For those unable to participate in the live session, a replay will remain archived in the Investor ...

Xiamen, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Star Fashion Culture Holdings Limited (“Star Fashion” or the “Company”) today announced the pricing on October 10, 2024 of its initial public offering ...

Autonomous Group 2 eVTOL UAS, Ushers in a New Era of Battlefield Adaptability and Mission Flexibility for Maneuver Forces ...